Key Dates

Related Announcements

NOT-HL-19-678 - Notice of Special Interest (NOSI): Bold New Bioengineering Research for Heart, Lung, Blood and Sleep Disorders and Diseases

NOT-HL-20-796 - Notice of Special Interest (NOSI): Bold New Bioengineering Research for Heart, Lung, Blood and Sleep Disorders and Diseases (Reissue)

PA-20-195 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform the extramural research community of changes to NOT-HL-19-678,as follows:

• Applications in response to NOT-HL-19-678 for due dates of June 16, 2020 and July 16, 2020 must be submitted through NIH Parent Announcement PA-20-195 "NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)"
• NOT-HL-19-678 "Notice of Special Interest (NOSI): Bold New Bioengineering Research for Heart, Lung, Blood and Sleep Disorders and Diseases" will expire on July 17, 2020. As a consequence of this expiration date, no AIDS applications will be accepted for the September 7, 2020 AIDS application due date.
• Applications will continue to be accepted for NOT-HL-19-678 through July 16, 2020 by 5:00 PM local time of the applicant organization. An application submitted in response to NOT-HL-19-678 that is received on July 17, 2020 or later will be withdrawn.

For dates after July 16, 2020, applicants, including applicants intending an AIDS focus,can consider applying toNOT-HL-20-796 “Notice of Special Interest (NOSI): Bold New Bioengineering Research for Heart, Lung, Blood and Sleep Disorders and Diseases" which serves to replace NOT-HL-19-678.

Inquiries

Please direct all inquiries to:

Martha S. Lundberg, Ph.D.
Division of Cardiovascular Sciences
Telephone: 301-435-0513
Email: lundberm@nhlbi.nih.gov